View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 400, Melanoma, adjuvant
Protocol-ID: 1251 V1.0 (Mini), PEMB400, Melanoma, adj.Indication(s)
- Melanoma, Malignant; ICD-10 C44.-
Links
- Pembrolizumab (keytruda) [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 22.05.2019